Search Results - "Sozaeva, Zhannet A"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Influence of ABCB1 3435C>T polymorphism on methotrexate safety in patients with psoriasis by Kubanov, Alexey A., Asoskova, Anastasiia V., Zastrozhin, Michael S., Sozaeva, Zhannet A., Sychev, Dmitry A.

    Published in Vestnik dermatologij i venerologij (26-02-2023)
    “…Background. Methotrexate is a highly effective systemic treatment for moderate to severe psoriasis, but drug toxicity may limit its use. Recent evidence…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole by Denisenko, Natalia P, Sychev, Dmitriy A, Sizova, Zhanna M, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A

    Published in Pharmacogenomics and personalized medicine (01-01-2018)
    “…Proton pump inhibitors (PPIs) are metabolized by cytochrome P450. CYP2C19 is the main isoenzyme for the majority of PPI, whereas CYP3A family is a secondary…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients by Denisenko, Natalia P, Sychev, Dmitriy A, Sizova, Zhanna M, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A

    Published in Pharmacogenomics and personalized medicine (01-01-2017)
    “…CYP2C19 is known to be the main enzyme of biotransformation of proton pump inhibitors (PPIs), whereas the gene is highly polymorphic. Genotyping and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19 by Temirbulatov, I. I., Kryukov, A. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, Sh. P., Kachanova, A. A., Sozaeva, Zh. A., Zhiryakova, A. S., Shevchuk, Yu. V., Vechorko, V. I., Averkov, O. V., Sychev, D. A.

    Published in Medicinskij sovet (18-01-2023)
    “…Introduction . An outbreak of novel COVID-19 infection has become a real challenge for the entire human society, and first of all for the healthcare services…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Urine metabolic ratio of omeprazole in relation to CYP2C 19 polymorphisms in Russian peptic ulcer patients by Denisenko, Natalia P, Sychev, Dmitriy A, Sizova, Zhanna M, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A

    Published in Pharmacogenomics and personalized medicine (01-01-2017)
    “…Background: CYP2C 19 is known to be the main enzyme of biotransformation of proton pump inhibitors (PPIs), whereas the CYP2C19 gene is highly polymorphic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17